Clinical Trials Browser

Phase 2 × Active not recruiting × Capsules × Clear all

NCT03753685 2025-07-23

X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases

Phase 2 Active not recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung